Nov 9 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2018 Sep 30, 2017 Dec 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8 mln 19 mln 8 mln
(-57.1 pct) (-11.8 pct) (-95.8 pct)
Operating loss 947 mln loss 813 mln loss 1.40
Recurring loss 958 mln loss 817 mln loss 1.41
Net loss 940 mln loss 712 mln loss 1.39
EPS loss 94.71 yen loss 83.65 yen loss 139.31 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T